|
|
Office Locations:
|
450 Brookline Ave.
Boston, MA 02215
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 2021, Binney Street Capital was established to build on Dana-Farber's legacy of scientific breakthroughs and compassionate care. As Dana-Farber Cancer Institute's venture fund, the firm invests in innovative companies by leveraging technologies or expertise from the Institute. Although the firm's main focus is oncology therapeutics and diagnostics, Binney pursues opportunities across a variety of disease areas and sectors to maximize patient impact. Binney invests across the innovation life cycle from company creation through early clinical validation. The firm plans to invest in eight to 10 companies over the next three years, with $250K - $2M per investment
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
